Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 5
2008 5
2009 2
2010 3
2011 8
2012 9
2013 11
2014 15
2015 13
2016 28
2017 20
2018 12
2019 19
2020 25
2021 14
2022 19
2023 13
2024 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.
Reply by Authors.
Rickey LM, Constantine ML, Lukacz ES, Lowder JL, Newman DK, Brubaker L, Rudser K, Lewis CE, Low LK, Palmer MH, Rockwood T. Rickey LM, et al. Among authors: rudser k. J Urol. 2021 May;205(5):1414. doi: 10.1097/JU.0000000000001581.02. Epub 2021 Mar 17. J Urol. 2021. PMID: 33728941 No abstract available.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
Urination Frequency Ranges in Healthy Women.
Wyman JF, Cain CH, Epperson CN, Fitzgerald CM, Gahagan S, Newman DK, Rudser K, Smith AL, Vaughan CP, Sutcliffe S; Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium. Wyman JF, et al. Among authors: rudser k. Nurs Res. 2022 Sep-Oct 01;71(5):341-352. doi: 10.1097/NNR.0000000000000595. Epub 2022 Mar 22. Nurs Res. 2022. PMID: 35319538 Free PMC article.
Lower Urinary Tract Symptoms in US Women: Contemporary Prevalence Estimates from the RISE FOR HEALTH Study.
Sutcliffe S, Falke C, Fok CS, Griffith JW, Harlow BL, Kenton KA, Lewis CE, Low LK, Lowder JL, Lukacz ES, Markland AD, McGwin G, Meister MR, Mueller ER, Newman DK, Pakpahan R, Rickey LM, Rockwood T, Simon MA, Smith AR, Rudser KD, Smith AL. Sutcliffe S, et al. Among authors: rudser kd. J Urol. 2024 Jul;212(1):124-135. doi: 10.1097/JU.0000000000004009. Epub 2024 May 4. J Urol. 2024. PMID: 38703067
184 results